ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,381.60
0.34%
S&P ASX All Technology
3,882.70
0.82%
Brent Oil
73.445
0.00%
US Dollar vs AUD
1.5674
0.05%
Bitcoin
100,991.77
-0.20%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Tango Therapeutics Inc (TNGX) Share Price

Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

NASDAQ
3.10
-0.21
(-6.34%)
At close: 12 December 8:00AM
Delayed by 15 minutes
3.10
0.01
( 0.32% )
After Hours: 10:55AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.10
Bid
3.12
Offer
3.29
Volume
1,165,620
3.09 Day's Range 3.40
2.70 52 Week Range 13.005
Market Cap
332.995M
Previous Close
3.31
Open
3.39
Last Trade
1
@
3.11
Last Trade Time
08:30:27
Financial Volume
US$ 3,678,092
VWAP
3.1555
Average Volume (3m)
1,843,151
Shares Outstanding
107,417,818
Dividend Yield
-
PE Ratio
-3.26
Earnings Per Share (EPS)
-0.95
Revenue
36.53M
Net Profit
-101.74M

About Tango Therapeutics Inc

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.tangotx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was US$3.31. Over the last year, Tango Therapeutics shares have traded in a share price range of US$ 2.70 to US$ 13.005.

Tango Therapeutics currently has 107,417,818 shares in issue. The market capitalisation of Tango Therapeutics is US$355.55 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -3.26.

Ask ADVFN Intelligence (AI)

TNGX Latest News

More News

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

03 December 2024
Business Wire

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

27 November 2024
Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 November 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

08 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

07 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

06 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 November 2024
Edgar (US Regulatory)

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...

06 November 2024
Business Wire

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

– TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...

06 November 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.59-15.98915989163.693.763.0911228923.39595949CS
4-0.29-8.554572271393.394.223.0917599343.75351185CS
12-5.52-64.03712296988.628.982.718431514.61199593CS
26-3.99-56.27644569827.0912.0152.713380076.40079511CS
52-6.14-66.45021645029.2413.0052.79829307.33942445CS
156-7.94-71.920289855111.0413.032.476953747.28905753CS
260-6.51-67.74193548399.6118.842.476455747.50538918CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMPGAmplitech Group Inc
US$ 3.04
(57.51%)
15.67M
CTHRCharles and Colvard Ltd
US$ 2.27
(44.58%)
3.1M
DBVTDBV Technologies SA
US$ 4.3787
(33.09%)
1.35M
AHGAkso Health Group
US$ 1.03
(17.42%)
140
SGRPSpar Group Inc
US$ 2.13
(14.52%)
1.06M
SPGCSacks Parente Golf Inc
US$ 0.82
(-41.43%)
67.42k
AVGRAvinger Inc
US$ 0.5799
(-29.28%)
89.39k
BCTXBriaCell Therapeutics Corporation
US$ 0.7917
(-28.03%)
1.07M
TFFPTFF Pharmaceuticals Inc
US$ 0.1235
(-24.09%)
968.05k
SXTP60 Degrees Pharmaceuticals Inc
US$ 1.88
(-14.93%)
102.74k
AMPGAmplitech Group Inc
US$ 3.04
(57.51%)
15.67M
LAESSEALSQ Corporation
US$ 1.14
(-0.87%)
8.69M
RGTIRigetti Computing Inc
US$ 7.1598
(-2.98%)
6.38M
TSLATesla Inc
US$ 429.50
(1.11%)
3.36M
APDNApplied DNA Sciences Inc
US$ 0.2289
(6.47%)
3.27M

TNGX Discussion

View Posts
Monksdream Monksdream 5 months ago
TNGX under $10
👍️0
Monksdream Monksdream 7 months ago
TNGX under $10
👍️0
bikaver bikaver 1 year ago
Stopped out with small loss.
👍️0
bikaver bikaver 1 year ago
TNGX......Holding up well, but will tumble soon.
👍️0
bikaver bikaver 1 year ago
TNGA.....short @ 8.60 This is the strength that I wanted to see!
👍️0
bikaver bikaver 1 year ago
TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.
👍️0
SmokeSignals SmokeSignals 1 year ago
up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS
👍️0

Your Recent History

NASDAQ
TNGX
Tango Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved